Claudin‐4 Expression Is Associated With Disease‐Free Survival in Breast Carcinoma‐in‐Situ: Mean Follow‐up of 8.2 Years

[1]  S. Pinder,et al.  Addressing overtreatment of screen detected DCIS; the LORIS trial. , 2015, European journal of cancer.

[2]  S. Shak,et al.  A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone , 2015, Breast Cancer Research and Treatment.

[3]  M. Abd-Elazeem,et al.  Claudin 4 expression in triple-negative breast cancer: correlation with androgen receptors and Ki-67 expression. , 2015, Annals of diagnostic pathology.

[4]  John M S Bartlett,et al.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  R. Tavares,et al.  Claudin Expression in High Grade Invasive Ductal Carcinoma of the Breast: Correlation with the Molecular Subtype , 2012, Modern Pathology.

[6]  F. Schmitt,et al.  Claudin expression in breast cancer: high or low, what to expect? , 2012, Histology and histopathology.

[7]  B. Győrffy,et al.  Identification of a claudin‐4 and E‐cadherin score to predict prognosis in breast cancer , 2011, Cancer science.

[8]  Jason I. Herschkowitz,et al.  Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer , 2010, Breast Cancer Research.

[9]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Archives of pathology & laboratory medicine.

[10]  Jeffrey M. Rosen,et al.  Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features , 2009, Proceedings of the National Academy of Sciences.

[11]  Nicholas J. Wang,et al.  Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. , 2009, Cancer research.

[12]  R. Millikan,et al.  Increased claudin‐4 expression is associated with poor prognosis and high tumour grade in breast cancer , 2009, International journal of cancer.

[13]  Z. Nemeth,et al.  Expression of Tight Junction Protein Claudin-4 in Basal-Like Breast Carcinomas , 2009, Pathology & Oncology Research.

[14]  Zhiyuan Hu,et al.  Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors , 2007, Genome Biology.

[15]  C. Sheehan,et al.  Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas. , 2007, Human pathology.

[16]  R. Kåresen,et al.  Expression pattern of adhesion molecules (E‐cadherin, α‐, β‐, γ‐catenin and claudin‐7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis , 2007 .

[17]  Kyle J Hewitt,et al.  The claudin gene family: expression in normal and neoplastic tissues , 2006, BMC Cancer.

[18]  A. Tőkés,et al.  Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study , 2005, Breast Cancer Research.

[19]  M. Katoh,et al.  CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family. , 2003, International journal of molecular medicine.

[20]  P. Argani,et al.  Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast , 2003, Oncogene.

[21]  Kazushi Fujimoto,et al.  Claudin-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions with No Sequence Similarity to Occludin , 1998, The Journal of cell biology.

[22]  H. Aberle,et al.  Cadherin‐catenin complex: Protein interactions and their implications for cadherin function , 1996, Journal of cellular biochemistry.

[23]  P. Nava,et al.  Tight junction proteins. , 2003, Progress in biophysics and molecular biology.